OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular endothelial growth factor receptor 2 (VEGFR‐2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
Arend H. Sikkema, Eveline S.J.M. de Bont, Grietje Molema, et al.
Neuropathology and Applied Neurobiology (2011) Vol. 37, Iss. 5, pp. 538-548
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee, Regina I. Jakacki, Arzu Onar‐Thomas, et al.
Neuro-Oncology (2017) Vol. 19, Iss. 8, pp. 1135-1144
Open Access | Times Cited: 280

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Karl H. Plate, Alexander Scholz, Daniel Dumont
Acta Neuropathologica (2012) Vol. 124, Iss. 6, pp. 763-775
Open Access | Times Cited: 236

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology (2013) Vol. 16, Iss. 2, pp. 310-317
Open Access | Times Cited: 149

EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion
Arend H. Sikkema, Wilfred F.A. den Dunnen, Esther Hulleman, et al.
Neuro-Oncology (2012) Vol. 14, Iss. 9, pp. 1125-1135
Open Access | Times Cited: 52

Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study
Carlien A. M. Bennebroek, J. van Zwol, Giorgio L. Porro, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6087-6087
Open Access | Times Cited: 21

Brain Distribution of Cediranib Is Limited by Active Efflux at the Blood-Brain Barrier
Tianli Wang, Sagar Agarwal, William F. Elmquist
Journal of Pharmacology and Experimental Therapeutics (2012) Vol. 341, Iss. 2, pp. 386-395
Open Access | Times Cited: 42

Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights
Soumen Khatua, David H. Gutmann, Roger J. Packer
Pediatric Blood & Cancer (2017) Vol. 65, Iss. 3
Closed Access | Times Cited: 32

The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients
Charles de Marcellus, Arnault Tauziède‐Espariat, Aurélie Cuinet, et al.
Journal of Neuro-Oncology (2022) Vol. 157, Iss. 2, pp. 355-364
Open Access | Times Cited: 16

The molecular biology of WHO grade I astrocytomas
N. F. Marko, Robert J. Weil
Neuro-Oncology (2012) Vol. 14, Iss. 12, pp. 1424-1431
Open Access | Times Cited: 28

Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma
Mariska Sie, Wilfred F.A. den Dunnen, Harm Jan Lourens, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0122555-e0122555
Open Access | Times Cited: 23

Anti-angiogenic therapy in pediatric brain tumors: An effective strategy?
Mariska Sie, Wilfred F.A. den Dunnen, Eelco W. Hoving, et al.
Critical Reviews in Oncology/Hematology (2013) Vol. 89, Iss. 3, pp. 418-432
Closed Access | Times Cited: 20

Innovations in studying in vivo cell behavior and pharmacology in complex tissues – microvascular endothelial cells in the spotlight
Elise Langenkamp, Jan A. A. M. Kamps, Michal Mrug, et al.
Cell and Tissue Research (2013) Vol. 354, Iss. 3, pp. 647-669
Closed Access | Times Cited: 20

Optimizing targeted cancer therapy: Towards clinical application of systems biology approaches
Arend H. Sikkema, Wilfred F.A. den Dunnen, Sander H. Diks, et al.
Critical Reviews in Oncology/Hematology (2011) Vol. 82, Iss. 2, pp. 171-186
Closed Access | Times Cited: 19

Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry
Tianyao Guo, Xiaowei Wang, Maoyu Li, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-21
Open Access | Times Cited: 17

Drug penetration in pediatric brain tumors: Challenges and opportunities
Jenny Patel, Susan Spiller, Elizabeth Barker
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 6
Closed Access | Times Cited: 14

Improving outcomes for neurofibromatosis 1–associated brain tumors
Nicole M Brossier, David H. Gutmann
Expert Review of Anticancer Therapy (2015) Vol. 15, Iss. 4, pp. 415-423
Closed Access | Times Cited: 13

An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies
Ying Chen, Jie Yu, Shengfang Ge, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 6, pp. 8-8
Open Access | Times Cited: 1

Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas
Yufei Gao, Piyong Ma, Yichun He, et al.
Molecular Neurobiology (2015) Vol. 53, Iss. 4, pp. 2541-2549
Closed Access | Times Cited: 9

Bevacizumab Use in Refractory Adult Pilocytic Astrocytoma
Ivan D. Carabenciov, Adip G. Bhargav, Joon H. Uhm, et al.
The Neurologist (2019) Vol. 24, Iss. 3, pp. 87-89
Closed Access | Times Cited: 8

Kinome Profiling
Maikel P. Peppelenbosch
Scientifica (2012) Vol. 2012, pp. 1-13
Open Access | Times Cited: 8

Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components
Carlien A. M. Bennebroek, Christiaan R Schouten, Maartje C Montauban-van Swijndregt, et al.
Journal of Neuro-Oncology (2023) Vol. 166, Iss. 1, pp. 79-87
Closed Access | Times Cited: 2

Genetics of Cerebellar Low-Grade Astrocytomas
Adam Fleming, Mark W. Kieran
Springer eBooks (2015), pp. 431-446
Closed Access | Times Cited: 1

Management of Children with Optic Gliomas and Neurofibromatosis Type 1
Giorgio Attinà, Palma Maurizi, Silvia Triarico, et al.
Biomedical & Pharmacology Journal (2020) Vol. 13, Iss. 4, pp. 1601-1606
Open Access | Times Cited: 1

Tumors of the Brain and Spinal Cord
Mark W. Kieran, Susan Chi, Peter Manley, et al.
Elsevier eBooks (2015), pp. 1779-1885.e42
Closed Access

Page 1 - Next Page

Scroll to top